Skip to content

Evaluation of Balance and Gait Weight Distribution in Patients With Vertebral Column Fractures

Evaluation of Balance and Gait Weight Distribution in Patients With Vertebral Column Fractures

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05010135
Enrollment
80
Registered
2021-08-18
Start date
2021-01-25
Completion date
2021-08-31
Last updated
2021-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balance, Gait, Unsteady, Vertebral Fracture

Keywords

Vertebral fracture, Balance, Gait

Brief summary

Vertebral column fracture presents a significant warning of subsequent osteoporotic fracture and frequent falls. The presence of an osteoporotic vertebral fracture is also a predictor of further risk of vertebral and other osteoporotic fractures. This study provides balance assessment and gait evaluation for subjects with a known vertebral fracture. Subjects are the known cases of vertebral fracture living in the community. They will be assessed for their balance and gait weight distribution by the TechnoBody for their balance ability, and the Zebris Gait System for the gait weight distribution. The Humac Norm for the lower limb muscle strength.

Detailed description

This study evaluates the balance and weight distribution in walking gait in subjects with vertebral column fracture, comparing with the healthy subjects. Study Objectives: 1. To evaluate the balance and gait weight distribution of the vertebral fracture patients. 2. To analyze the association between balance and gait weight distribution with fall risks in patients with stable vertebral fractures. 3. To construct a community fall prevention protocol. Methodology: Subjects:80 ambulatory subjects with a history of vertebral fracture, aged 60 and above, will be recruited from the community. Study Design: an observational study by convenient sampling design. Sample size calculation: The calculated sample size of vertebral column fractures is 64. Allowing a 20% dropout rate, the round-up figure is 80. Assessments will include the following: 1. . A questionnaire to collect the following information: i. Subjects' demographics, medical and medication history, and fall history. ii. Numeric Pain Rating Scale; ii. Roland-Morris Disability Questionnaire; iii. Oswestry Disability Index (Chinese version); iv. SF-12; 2. A 6-meters Up and Go test; 3. Hand Grip Strength to evaluate the muscle strength of the subjects 4. Flexibility measurement (how far to lean forward); 5. Balance and Centre of Gravity evaluation by the TechnoBody Machine; 6. . Zebris Gait System for their gait weight distribution evaluation, and 7. Humac Norm for the Quadriceps and Hamstrings muscle strength (both sides). Statistical Analysis: 1. Statistical analyses will be performed using SPSS (version 24). 2. Two-sided tests and an α-level of 5% were used as the level of significance. 3. Chi-square tests were used for categorical variables. 4. Two-sample independent t-tests were used for continuous variables. The balance, gait weight distribution pattern, and muscle strength will be analyzed by ANOVA. Correlation analysis will be conducted for the factors of gender, age, and comorbid conditions. From the results, strategies for fall prevention will be modelled and formulated. Inclusion Criteria: 1. All subjects are aged 60 or above with a history of vertebral fracture, and able to walk without assistance; 2. Not received a bilateral hip replacement and spinal surgery; 3. No known malignance at time of enrollment; 4. Able to attend Tung Wah College for examination and assessment, understand, and sign the consent form. Exclusion criteria: 1. Unable to attend the research center for receiving examination and tests; 2. Unable to give consent; 3. Diseases such as stroke and Parkinson's Disease that adversely affect the balance and gait weight distribution; 4. Bed-bound or wheel-chair bound patients.

Interventions

DEVICEZebris Gait System assessment for gait weight distribution + EMG evaluation of Quadriceps, Hamstrings, Tib Anterior and Calves + Positional Sense assessment

To measure the above parameters and to compare between the healthy subjects and the vertebral fracture subjects

Sponsors

Tung Wah College
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum

Inclusion criteria

1. All subjects are aged 60 or above with a history of vertebral fracture, and able to walk without assistance; 2. Not received bilateral hip replacement and spinal surgery; 3. No known malignance at time of enrollment; 4. Able to attend Tung Wah College for examination and assessment, understand and sign the consent form.

Exclusion criteria

1. Unable to attend the research center for receiving examination and tests; 2. Unable to give consent; 3. Diseases such as stroke and Parkinson's Disease that adversely affect the balance and gait weight distribution; 4. Bed bound or wheel-chair bound patients.

Design outcomes

Primary

MeasureTime frameDescription
Balance (measure by the TechnoBody machine to show the amplitude of body displacement from the centre)Up to 24 weekscompare between the 2 groups
Gait weight distribution (measure by the Zebris Rehabwalk machine to show the force in Newton)Up to 24 weekscompare between the 2 groups

Secondary

MeasureTime frameDescription
Muscle strength (measure by the Humac Norm machine to evaluate the Quadriceps and Hamstrings strength in Peak Torque, N)Up to 24 weeksCompare between the 2 groups
Positional senses (measure by the position sensor attached on the feet, legs, thighs, lumber spine, thoracic spine and the cervical spine to show the body displacement in angle degrees).Up to 24 weeksCompare between the 2 groups
Low Back Pain (measure by the Oswestry Disability Index and Roland Morris Disability Questionnaire)Up to 24 weeksCompare between the 2 groups
Quality of Life evaluation (measure by the SF-12 questionnaire)Up to 24 weeksCompare between 2 groups

Countries

Hong Kong

Contacts

Primary ContactAnthony WL Kwok, Ph.D
anthonykwok@twc.edu.hk+85296336734
Backup ContactGrace PY Szeto, Ph.D
graceszeto@twc.edu.hk+8523468 6721

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026